+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Disposable Syringes Market Share, Size, Trends, Industry Analysis Report, By Application; By Type; By Region; Segments & Forecast, 2021 - 2028

  • PDF Icon

    Report

  • 114 Pages
  • July 2021
  • Region: Global
  • Polaris Market Research
  • ID: 5396982
The global disposable syringes market size is expected to reach USD 11.75 billion by 2028 according to this new study. The report “Disposable Syringes Market Share, Size, Trends, Industry Analysis Report, By Application (Immunization Injections, Therapeutic Injections); By Type; By Region; Segments & Forecast, 2021-2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.



Use-and-throw types of products are more reliable than other types in the self-administration of drugs, owing to many safety features accompanying them. This is especially valid for point of care systems which is currently advocating the self-administration of drugs.

Intravenous and Intramuscular are the two chosen modes of drug delivery. Disposable ones are to be relied upon to give medication through the above two modes, namely intravenous and intramuscular. They are cost-conscious and keep infection at bay. They score over conventional types here.

North America is a leader in the segment but soon will be offset by expanding Asia pacific in the forecast period. The drivers to the disposables industry can be attributed to favorable government initiatives and directives that have pursued industry growth. Government initiatives to check the spread of fatal diseases such as HIV also boost the industry over the coming years.

Europe is the second-largest market in the forecast period. Both America and Europe will consolidate share owing to a higher number of injectable drugs that are occupying volume lately. Furthermore, concerns of stick injuries and improvements in quality have given impetus to growth.

The key players include UltiMed, Inc., Terumo Corporation., Novo Nordisk AG, Henke-Sass, Wolf, Braun Medical, Inc., Covidien, Retractable Technologies, Inc. Fresenius Kabi AG., Becton, Dickinson and Company, Flextronics International Vita Needle Company, and Baxter International, Inc.

The publisher has segmented the disposable syringes market report on the basis of type, application, and region:


Disposable Syringes, Type Outlook (Revenue-USD Million, 2016-2028)


  • Safety Syringes
  • Conventional Syringes

Disposable Syringes, Application Outlook (Revenue-USD Million, 2016-2028)


  • Immunization Injections
  • Therapeutic Injections

Disposable Syringes, Regional Outlook (Revenue-USD Million, 2016-2028)


  • North America
  • U.S.
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Spain
  • Netherlands
  • Austria
  • Asia Pacific
  • China
  • India
  • Japan
  • Malaysia
  • South Korea
  • Indonesia
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
Frequently Asked Questions about the Disposable Syringes Market

What is the estimated value of the Disposable Syringes Market?

The Disposable Syringes Market was estimated to be valued at $7.55 Billion in 2021.

What is the growth rate of the Disposable Syringes Market?

The growth rate of the Disposable Syringes Market is 5.9%, with an estimated value of $11.75 Billion by 2028.

What is the forecasted size of the Disposable Syringes Market?

The Disposable Syringes Market is estimated to be worth $11.75 Billion by 2028.

Who are the key companies in the Disposable Syringes Market?

Key companies in the Disposable Syringes Market include UltiMed Inc., Terumo Corporation., Novo Nordisk AG, Henke, Sass, Wolf, Braun Medical Inc., Covidien and Becton.

Table of Contents

1. Overview and Scope
1.1. Research goal & scope
1.2. Research assumptions
1.3. Research Methodology
1.3.1. Primary data sources
1.3.2. Secondary data sources
1.4. Key takeaways
1.5. Stakeholders
2. Executive Summary
2.1. Market Definition
2.2. Market Segmentation
3. Disposable Syringe Market Insights
3.1. Disposable Syringe – Industry snapshot
3.2. Disposable Syringe - Ecosystem analysis
3.3. Disposable Syringe Market Dynamics
3.3.1. Disposable Syringe – Market Forces
3.3.1.1. Disposable Syringe Market Driver Analysis
3.3.1.2. Disposable Syringe Market Restraint/Challenges analysis
3.3.1.3. Disposable Syringe Market Opportunity Analysis
3.4. Industry analysis - Porter's five force
3.4.1. Bargaining power of supplier
3.4.2. Bargaining power of buyer
3.4.3. Threat of substitute
3.4.4. Threat of new entrant
3.4.5. Degree of competition
3.5. Disposable Syringe Market PEST Analysis
3.6. Disposable Syringe Market Value Chain Analysis
3.7. Disposable Syringe Industry Trends
3.8. Competitive Ranking Analysis
4. Disposable Syringe Market Size and Forecast by Type, 2018-2026
4.1. Key Findings
4.2. Safety Syringes
4.3. Conventional Syringes
5. Disposable Syringe Market Size and Forecast by Application Type, 2018-2026
5.1. Key Findings
5.2. Immunization Injections
5.3. Therapeutic Injections
6. Disposable Syringe Market Size and Forecast by Region, 2018-2026
6.1. Key Findings
6.2. North America
6.2.1. U.S.
6.2.2. Canada
6.3. Europe
6.3.1. Germany
6.3.2. UK
6.3.3. France
6.3.4. Italy
6.3.5. Spain
6.3.6. Netherlands
6.3.7. Austria
6.4. Asia-Pacific
6.4.1. China
6.4.2. India
6.4.3. Japan
6.4.4. South Korea
6.4.5. Indonesia
6.4.6. Thailand
6.5. Latin America
6.5.1. Mexico
6.5.2. Brazil
6.5.3. Argentina
6.6. Middle East & Africa
6.6.1. UAE
6.6.2. Saudi Arabia
6.6.3. South Africa
6.6.4. Israel
7. Company Profiles
7.1. Fresenius Kabi AG.
7.1.1. Overview
7.1.2. Financials
7.1.3. Product Benchmarking
7.1.4. Recent Developments
7.2. Becton, Dickinson, and Company
7.2.1. Overview
7.2.2. Financials
7.2.3. Product Benchmarking
7.2.4. Recent Developments
7.3. Flextronics International Vita Needle Company.
7.3.1. Overview
7.3.2. Financials
7.3.3. Product Benchmarking
7.3.4. Recent Developments
7.4. Baxter International, Inc.
7.4.1. Overview
7.4.2. Financials
7.4.3. Product Benchmarking
7.4.4. Recent Developments
7.5. UltiMed, Inc.
7.5.1. Overview
7.5.2. Financials
7.5.3. Product Benchmarking
7.5.4. Recent Developments
7.6. Terumo Corporation.
7.6.1. Overview
7.6.2. Financials
7.6.3. Product Benchmarking
7.6.4. Recent Developments
7.7. Novo Nordisk AG
7.7.1. Overview
7.7.2. Financials
7.7.3. Product Benchmarking
7.7.4. Recent Developments
7.8. Henke-Sass.
7.8.1. Overview
7.8.2. Financials
7.8.3. Product Benchmarking
7.8.4. Recent Developments
7.9. Wolf
7.9.1. Overview
7.9.2. Financials
7.9.3. Product Benchmarking
7.9.4. Recent Developments
7.10. Braun Medical, Inc.
7.10.1. Overview
7.10.2. Financials
7.10.3. Product Benchmarking
7.10.4. Recent Developments
7.11. Covidien
7.11.1. Overview
7.11.2. Financials
7.11.3. Product Benchmarking
7.11.4. Recent Developments
7.12. Retractable Technologies, Inc
7.12.1. Overview
7.12.2. Financials
7.12.3. Product Benchmarking
7.12.4. Recent Developments
List of Tables
N/A

Companies Mentioned

  • UltiMed Inc.
  • Terumo Corporation.
  • Novo Nordisk AG
  • Henke-Sass
  • Wolf
  • Braun Medical Inc.
  • Covidien
  • Retractable Technologies Inc. Fresenius Kabi AG.
  • Becton
  • Dickinson
  • Company
  • Flextronics International Vita Needle Company
  • Baxter International Inc